GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Coloplast A/S (LTS:0QBO) » Definitions » Cyclically Adjusted Price-to-FCF

Coloplast A/S (LTS:0QBO) Cyclically Adjusted Price-to-FCF : 53.64 (As of May. 21, 2024)


View and export this data going back to 2007. Start your Free Trial

What is Coloplast A/S Cyclically Adjusted Price-to-FCF?

As of today (2024-05-21), Coloplast A/S's current share price is kr848.60. Coloplast A/S's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 was kr15.82. Coloplast A/S's Cyclically Adjusted Price-to-FCF for today is 53.64.

The historical rank and industry rank for Coloplast A/S's Cyclically Adjusted Price-to-FCF or its related term are showing as below:

LTS:0QBO' s Cyclically Adjusted Price-to-FCF Range Over the Past 10 Years
Min: 41.66   Med: 59.16   Max: 86.54
Current: 53.49

During the past years, Coloplast A/S's highest Cyclically Adjusted Price-to-FCF was 86.54. The lowest was 41.66. And the median was 59.16.

LTS:0QBO's Cyclically Adjusted Price-to-FCF is ranked worse than
61.02% of 236 companies
in the Medical Devices & Instruments industry
Industry Median: 44.395 vs LTS:0QBO: 53.49

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Coloplast A/S's adjusted free cash flow per share data for the three months ended in Mar. 2024 was kr-12.612. Add all the adjusted free cash flow per share for the past 10 years together and divide 10 will get our Cyclically Adjusted FCF per Share, which is kr15.82 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Coloplast A/S Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Coloplast A/S's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Coloplast A/S Cyclically Adjusted Price-to-FCF Chart

Coloplast A/S Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 65.24 72.94 68.89 46.43 44.66

Coloplast A/S Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 54.19 51.70 44.66 45.24 58.68

Competitive Comparison of Coloplast A/S's Cyclically Adjusted Price-to-FCF

For the Medical Instruments & Supplies subindustry, Coloplast A/S's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Coloplast A/S's Cyclically Adjusted Price-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Coloplast A/S's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Coloplast A/S's Cyclically Adjusted Price-to-FCF falls into.



Coloplast A/S Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Coloplast A/S's Cyclically Adjusted Price-to-FCF for today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/ Cyclically Adjusted FCF per Share
=848.60/15.82
=53.64

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Coloplast A/S's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Coloplast A/S's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-12.612/118.4000*118.4000
=-12.612

Current CPI (Mar. 2024) = 118.4000.

Coloplast A/S Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 3.971 99.700 4.716
201409 4.694 99.700 5.574
201412 2.313 99.400 2.755
201503 0.211 100.200 0.249
201506 4.556 100.300 5.378
201509 5.713 100.200 6.751
201512 2.369 99.800 2.811
201603 1.703 100.200 2.012
201606 2.112 100.600 2.486
201609 5.020 100.200 5.932
201612 0.669 100.300 0.790
201703 0.725 101.200 0.848
201706 4.470 101.200 5.230
201709 6.196 101.800 7.206
201712 3.813 101.300 4.457
201803 1.320 101.700 1.537
201806 5.540 102.300 6.412
201809 6.715 102.400 7.764
201812 3.014 102.100 3.495
201903 1.498 102.900 1.724
201906 5.697 102.900 6.555
201909 7.254 102.900 8.347
201912 3.784 102.900 4.354
202003 1.689 103.300 1.936
202006 5.696 103.200 6.535
202009 6.788 103.500 7.765
202012 -0.085 103.400 -0.097
202103 2.430 104.300 2.759
202106 5.420 105.000 6.112
202109 7.824 105.800 8.756
202112 4.361 106.600 4.844
202203 -0.089 109.900 -0.096
202206 6.182 113.600 6.443
202209 8.189 116.400 8.330
202212 0.998 115.900 1.020
202303 1.874 117.300 1.892
202306 4.128 116.400 4.199
202309 6.662 117.400 6.719
202312 6.920 116.700 7.021
202403 -12.612 118.400 -12.612

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Coloplast A/S  (LTS:0QBO) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Coloplast A/S Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Coloplast A/S's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Coloplast A/S (LTS:0QBO) Business Description

Address
Holtedam 1-3, Humlebaek, DNK, DK-3050
Coloplast is a leading global competitor in ostomy management and continence care. The firm designs, manufactures, and markets ostomy care systems, disposable containment devices, paste, powder, seals, and intermittent catheters for continence care. Coloplast also maintains a tertiary presence in the urology and woundcare markets, where it manufactures and markets penile implants, slings for incontinence and prolapse, and wound dressings. The company derives more than 60% of sales from Europe, 24% from other developed countries, and 17% from the rest of the world.

Coloplast A/S (LTS:0QBO) Headlines

No Headlines